A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS)

Clinical trial NCT02714036 · COMPLETED

Trial details

NCT number: NCT02714036
Sponsor: MediciNova
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2016-05-06
Primary completion: 2019-12-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.